Amendments To Breakthrough Device Coverage Act Push Bill Out Of House Ways And Means Committee

The amendment introduced to the Ensuring Patient Access to Critical Breakthrough Products Act in the Ways and Means committee markup of helped usher the legislation to a passing vote.

• Source: Shutterstock

The Ensuring Patient Access to Critical Breakthrough Products Act of 2024 (HR1691) was approved by the US House Committee on Ways & Means on 27 June, supported by an amendment that tightened the criteria for breakthrough devices to be covered by the pathway.

The bipartisan bill, originally introduced by Representatives Suzan DelBene (D-WA) and Brad Wenstrup (R-OH) passed out of committee with a vote of 36-5, with Reps

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

More from Medtech Insight